Poll: What is your first-line approach to emergent presbyopes who wear contact lenses?

This poll is for optometrists and eyecare professionals, only. It will close on Friday, August 13, 2021.

What is your first-line approach to emergent presbyopes who wear contact lenses?

A. Multifocal contact lenses
B. Monovision contact lenses
C. Low-power readers over single-vision contact lenses
D. Low-power readers over single-vision contact lenses
Related Videos
Patrick Mooney, CEO of SpyGlass Pharma
Related Content

The future of optometry shines brightly at OIS @ SECO Innovation Showcase

March 8th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Orasis Pharmaceuticals’ NDA for CSF-1 for presbyopia accepted by FDA

February 21st 2023

Pegcetacoplan approved by FDA for the treatment of geographic atrophy

February 17th 2023

The future of optometry shines brightly at OIS @ SECO Innovation Showcase

March 8th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Orasis Pharmaceuticals’ NDA for CSF-1 for presbyopia accepted by FDA

February 21st 2023

Pegcetacoplan approved by FDA for the treatment of geographic atrophy

February 17th 2023

The future of optometry shines brightly at OIS @ SECO Innovation Showcase

March 8th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Orasis Pharmaceuticals’ NDA for CSF-1 for presbyopia accepted by FDA

February 21st 2023

Pegcetacoplan approved by FDA for the treatment of geographic atrophy

February 17th 2023
© 2023 MJH Life Sciences

All rights reserved.